tirzepatide after stopping Rebound Weight Gain (Mounjaro or Zepbound) Weight regain after stopping Tirzepatide
Description
Missing a dose of semaglutide can disrupt your weight loss progress, but knowing the right steps to take minimizes the impact on your treatment plan and metabolic response
Non-GLP-1 weight loss medications offer alternatives for patients who cannot tolerate GLP-1 agents or require different mechanisms of action
The FDA warns that patients are harming themselves using compounded semaglutide
The data supports continued use in: Type 2 diabetes Obesity and metabolic syndrome Patients with cardiometabolic risk factors Reasonable caution is still appropriate in individuals with: Active pancreatitis Recurrent idiopathic pancreatitis Severe hypertriglyceridemia until corrected
Mayo Clinic #PrecisionObesity #PrecisionBariatrics
